This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Analytical Chemistry Remove Clinical Development Remove Pharmaceuticals Related Topics
Licensing RNA Clinical Research Small Molecule DNA FDA Approval Trials Treatment Drug Development Disease More Related Topics >
article thumbnail

International Women’s Day: Female life science leaders

Drug Discovery World

MARCH 7, 2023

Dr Thomas has a background in biochemistry research at Leicester, Cambridge, and Glaxo, after which she has had 25 years of pharmaceutical drug discovery and development experience from large Pharma (GSK) and SMEs. See her interview with Megan Thomas at the Avacta Group Open Day.

International 246
International Science Pharmaceuticals DNA 246
article thumbnail

BioSpace Movers & Shakers, Nov. 6

The Pharma Data

NOVEMBER 5, 2020

X4 Pharmaceuticals – Art Taveras was named CSO of Cambridge, Mass.-based Taveras will lead all research and non-clinical development functions supporting the company’s pipeline of investigational therapies. Prior to this, he held a position as a director of Analytical Chemistry in Drug Discovery at GlaxoSmithKline.

Analytical Chemistry 40
Analytical Chemistry Pharmaceuticals Small Molecule Therapies 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024